Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19

Sachin J Shah; Peter N Barish; Priya A Prasad; Amy L Kistler; Norma Neff; Jack Kamm; Lucy M Li; Charles Y Chiu; Jennifer M Babick; Margaret C Fang; Yumiko Abe-Jones; Narges Alipanah; Francisco N Alvarez; Olga B Botvinnik; Jennifer M Davis; Gloria D Castenada; CLIAHub Consortium; Rand M Dadasovich; Xianding Deng; Joseph L DeRisi; Angela M Detweiler; Scot Federman; John R Haliburton; Samantha L Hao; Andrew D Kerkhoff; Renuka Kumar; Katherine Malcolm; Sabrina A Mann; Sandra P Martinez; Rupa Marya; Eran Mick; Lusajo L Mwakibete; Nader Najafi; Michael J Peluso; Maira S Phelps; Angela O Pisco; Kalani Ratnasiri; Luis A Rubio; Anna B Sellas; Kyla D Sherwood; Jonathan Sheu; Natasha Spottiswoode; Michelle Tan; Guixa Yu; Kirsten N Kangelaris; Charles Langelier.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20082461

Documentos relacionados

  1. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.
  2. RSV pneumonia with or without bacterial co-infection among healthy children.
  3. Old foes following news ways?-Pandemic-related changes in the epidemiology of viral respiratory tract infections.
  4. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.
  5. Metagenomic analysis reveals differences in the co-occurrence and abundance of viral species in SARS-CoV-2 patients with different severity of disease.
  6. The risk of hospitalisation from RSV is not increased by co-infection in children under 24-months-of-age.
  7. [Fathers and peripartum mental illness: the neglected parent?]
  8. The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.
  9. Low-dose tocilizumab is associated with improved outcome and a low risk of secondary infection in severe COVID-19 pneumonia.
  10. SARS-CoV-2 coinfection with additional respiratory virus does not predict severe disease: a retrospective cohort study.